查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1625409

個人化醫療生物標記市場，規模，佔有率，趨勢，產業分析報告:各適應症，各用途，各地區 - 市場預測，2025年～2034年

Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，個人化醫療生物標記市場預計到 2034 年將達到 782.7 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於對標靶治療和精準醫學的需求不斷增加，個人化醫療生物標記市場正在快速成長。生物標記是用於預測疾病風險、診斷病情和監測治療反應的生物指標。生物標記的應用涵蓋腫瘤學、神經病學、心臟病學和自體免疫疾病等重要領域，在這些領域，個人化方法可以顯著改善患者的治療結果。

市場成長是由生物標記技術的進步所推動的，包括能夠開發準確的診斷和治療解決方案的基因組和蛋白質組創新。癌症、糖尿病和心血管疾病等慢性病的盛行率不斷增加，進一步增加了對生物標記的需求，從而促進了早期檢測、治療選擇和監測等市場的成長。

製藥公司、診斷公司和研究機構之間的策略合作夥伴關係正在加速生物標誌物的開發和採用，為個人化醫療生物標記市場創造重大商機。此外，隨著老化社會變得更容易患慢性病和與年齡相關的疾病，對生物標記物的需求不斷增長，以便為該族群提供個人化治療。

個人化醫療生物標記市場報告亮點

從應用來看，由於針對個別患者狀況的精準治療需求不斷增加，治療選擇領域在 2024 年佔據了最大的市場佔有率。

由於全球糖尿病盛行率不斷上升，預計基於適應症的糖尿病細分市場在預測期內將出現最高的複合年增長率。

2024年，由於研發方面的大量投資，北美在個人化醫療生物標記市場佔據主導地位。

由於慢性病盛行率上升，預計亞太市場在預測期內將顯著成長。

全球主要市場企業，Laboratory Corporation of America Holding，Quest Diagnostics Incorporated，Agilent Technologies, Inc.，Genome Medical, Inc.，Coriell Life Sciences，Thermo Fisher Scientific Inc.，NeoGenomics Laboratories，FOUNDATION MEDICINE, INC.，Illumina, Inc.，Guardant 有Health等。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球個人化醫療生物標記市場洞察

  • 市場概述
  • 個人化醫療生物標記市場動態
    • 促進因素和機會
      • 慢性病的盛行率
      • 擴大製藥公司和診斷公司之間的合作
    • 阻礙因素與課題
      • 高開發成本
  • PESTEL分析
  • 個人化醫療生物標記市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球個人化醫療生物標記市場:各適應症

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 神經學
  • 糖尿病
  • 自體免疫疾病
  • 心臟病
  • 其他

第6章 全球個人化醫療生物標記市場:各用途

  • 主要調查結果
  • 簡介
  • 早期發現·篩檢
  • 診斷
  • 治療的選擇
  • 監視

第7章 全球個人化醫療生物標記市場:各地區

  • 主要調查結果
  • 簡介
    • 個人化醫療生物標記市場評估:各地區，2020年～2034年
  • 北美
    • 北美:各適應症，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各適應症，2020～2034年
    • 歐洲:各用途，2020年～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各適應症，2020年～2034年
    • 亞太地區:各用途，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各適應症，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各適應症，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • Laboratory Corporation of America Holding
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc.
  • Genome Medical, Inc.
  • Coriell Life Sciences.
  • Thermo Fisher Scientific Inc.
  • NeoGenomics Laboratories
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Guardant Health
Product Code: PM5290

The personalized medicine biomarkers market size is expected to reach USD 78.27 billion by 2034, according to a new study by Polaris Market Research. The report "Personalized Medicine Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Indication, Application (Early Detection/Screening, Diagnosis, Treatment Selection, and Monitoring), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The personalized medicine biomarkers market is rapidly growing due to the rising demand for targeted therapies and precision medicine. Biomarkers are biological indicators used to predict disease risk, diagnose conditions, and monitor treatment response. Biomarker applications are across critical areas such as oncology, neurology, cardiology, and autoimmune diseases, where personalized approaches significantly enhance patient outcomes.

Market growth is propelled by advancements in biomarker technologies, including genomic and proteomic innovations, which enable the development of precise diagnostic and therapeutic solutions. The increasing prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases further amplifies the demand for biomarkers, contributing to market growth such as early detection, treatment selection, and monitoring.

Strategic partnerships between pharmaceutical companies, diagnostic firms, and research organizations are accelerating biomarker development and adoption, creating significant personalized medicine biomarkers market opportunities. Furthermore, the aging population is more prone to chronic and age-related conditions, creating a higher demand for biomarkers to personalize treatments for this demographic.

Personalized Medicine Biomarkers Market Report Highlights

In terms of application, in 2024, the treatment selection segment accounted for the largest share of the market due to the growing demand for precision therapies tailored to individual patient profiles.

The diabetes segment, based on indication, is expected to witness the highest CAGR over the forecast period due to the rising global prevalence of diabetes.

In 2024, North America dominated the personalized medicine biomarkers market due to due to significant investments in research and development.

The Asia Pacific market is expected to witness significant growth over the forecast period due to the rising prevalence of chronic diseases.

A few global key market players include Laboratory Corporation of America Holding; Quest Diagnostics Incorporated; Agilent Technologies, Inc.; Genome Medical, Inc.; Coriell Life Sciences; Thermo Fisher Scientific Inc.; NeoGenomics Laboratories; FOUNDATION MEDICINE, INC.; Illumina, Inc.; Guardant Health.

Polaris Market Research has segmented the personalized medicine biomarkers market report on the indication, application, and region:

By Indication Outlook (Revenue, USD Billion; 2020-2034)

  • Oncology
  • By Type
  • § Breast Cancer
  • § Lung Cancer
  • § Colon Cancer
  • § Others
  • By Circulating Biomarkers
  • § Circulating Tumor Cells(CTCs)
  • § Circulating Cell-free DNA(cfDNA)
  • § Extracellular Vesicles (EVs)
  • § Other Circulating Biomarkers
  • Neurology
  • Diabetes
  • Autoimmune Diseases
  • Cardiology
  • Others

By Application Outlook (Revenue, USD Billion; 2020-2034)

  • Early Detection/Screening
  • Diagnosis
  • Treatment Selection
  • Monitoring

By Regional Outlook (Revenue, USD Billion; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Personalized Medicine Biomarkers Market Insights

  • 4.1. Personalized Medicine Biomarkers Market - Market Snapshot
  • 4.2. Personalized Medicine Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Rising Collaboration Between Pharmaceutical and Diagnostics Companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Development Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Personalized Medicine Biomarkers Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Personalized Medicine Biomarkers Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Personalized Medicine Biomarkers Market, by Oncology, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Type
      • 5.3.2.1. Global Personalized Medicine Biomarkers Market, by Type, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Breast Cancer
      • 5.3.2.2.1. Global Personalized Medicine Biomarkers Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Lung Cancer
      • 5.3.2.3.1. Global Personalized Medicine Biomarkers Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.4. Colon Cancer
      • 5.3.2.4.1. Global Personalized Medicine Biomarkers Market, by Colon Cancer, by Region, 2020-2034 (USD Billion)
      • 5.3.2.5. Others
      • 5.3.2.5.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Circulating Biomarkers
      • 5.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
      • 5.3.3.2. Circulating Tumor Cells(CTCs)
      • 5.3.3.2.1. Global Personalized Medicine Biomarkers Market, by Circulating Tumor Cells(CTCs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.3. Circulating Cell-free DNA(cfDNA)
      • 5.3.3.3.1. Global Personalized Medicine Biomarkers Market, by Circulating Cell-free DNA(cfDNA), by Region, 2020-2034 (USD Billion)
      • 5.3.3.4. Extracellular Vesicles (EVs)
      • 5.3.3.4.1. Global Personalized Medicine Biomarkers Market, by Extracellular Vesicles (EVs), by Region, 2020-2034 (USD Billion)
      • 5.3.3.5. Other Circulating Biomarkers
      • 5.3.3.5.1. Global Personalized Medicine Biomarkers Market, by Other Circulating Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Neurology
    • 5.4.1. Global Personalized Medicine Biomarkers Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 5.5. Diabetes
    • 5.5.1. Global Personalized Medicine Biomarkers Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 5.6. Autoimmune Diseases
    • 5.6.1. Global Personalized Medicine Biomarkers Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 5.7. Cardiology
    • 5.7.1. Global Personalized Medicine Biomarkers Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Personalized Medicine Biomarkers Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Personalized Medicine Biomarkers Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Early Detection/Screening
    • 6.3.1. Global Personalized Medicine Biomarkers Market, by Early Detection/Screening, by Region, 2020-2034 (USD Billion)
  • 6.4. Diagnosis
    • 6.4.1. Global Personalized Medicine Biomarkers Market, by Diagnosis, by Region, 2020-2034 (USD Billion)
  • 6.5. Treatment Selection
    • 6.5.1. Global Personalized Medicine Biomarkers Market, by Treatment Selection, by Region, 2020-2034 (USD Billion)
  • 6.6. Monitoring
    • 6.6.1. Global Personalized Medicine Biomarkers Market, by Monitoring, by Region, 2020-2034 (USD Billion)

7. Global Personalized Medicine Biomarkers Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Personalized Medicine Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Personalized Medicine Biomarkers Market - North America
    • 7.3.1. North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.2. North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Personalized Medicine Biomarkers Market - US
      • 7.3.3.1. US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.3.2. US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Personalized Medicine Biomarkers Market - Canada
      • 7.3.4.1. Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Personalized Medicine Biomarkers Market - Europe
    • 7.4.1. Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Personalized Medicine Biomarkers Market - UK
      • 7.4.3.1. UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Personalized Medicine Biomarkers Market - France
      • 7.4.4.1. France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Personalized Medicine Biomarkers Market - Germany
      • 7.4.5.1. Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Personalized Medicine Biomarkers Market - Italy
      • 7.4.6.1. Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Personalized Medicine Biomarkers Market - Spain
      • 7.4.7.1. Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Personalized Medicine Biomarkers Market - Netherlands
      • 7.4.8.1. Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Personalized Medicine Biomarkers Market - Russia
      • 7.4.9.1. Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Personalized Medicine Biomarkers Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Personalized Medicine Biomarkers Market - Asia Pacific
    • 7.5.1. Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Personalized Medicine Biomarkers Market - China
      • 7.5.3.1. China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Personalized Medicine Biomarkers Market - India
      • 7.5.4.1. India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Personalized Medicine Biomarkers Market - Malaysia
      • 7.5.5.1. Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Personalized Medicine Biomarkers Market - Japan
      • 7.5.6.1. Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Personalized Medicine Biomarkers Market - Indonesia
      • 7.5.7.1. Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Personalized Medicine Biomarkers Market - South Korea
      • 7.5.8.1. South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Personalized Medicine Biomarkers Market - Australia
      • 7.5.9.1. Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Personalized Medicine Biomarkers Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Personalized Medicine Biomarkers Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Personalized Medicine Biomarkers Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Personalized Medicine Biomarkers Market - UAE
      • 7.6.4.1. UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Personalized Medicine Biomarkers Market - Israel
      • 7.6.5.1. Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Personalized Medicine Biomarkers Market - South Africa
      • 7.6.6.1. South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Personalized Medicine Biomarkers Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Personalized Medicine Biomarkers Market - Latin America
    • 7.7.1. Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Personalized Medicine Biomarkers Market - Mexico
      • 7.7.3.1. Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Personalized Medicine Biomarkers Market - Brazil
      • 7.7.4.1. Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Personalized Medicine Biomarkers Market - Argentina
      • 7.7.5.1. Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Personalized Medicine Biomarkers Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Laboratory Corporation of America Holding
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Quest Diagnostics Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Agilent Technologies, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Genome Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Coriell Life Sciences.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Thermo Fisher Scientific Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. NeoGenomics Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. FOUNDATION MEDICINE, INC.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Illumina, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Guardant Health
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development

List of Tables:

Table 1 Global Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 2 Global Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 3 North America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 4 North America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 5 US: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 6 US: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 7 Canada: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 8 Canada: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 9 Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 10 Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 11 UK: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 12 UK: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 13 France: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 14 France: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 15 Germany: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 16 Germany: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 17 Italy: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 18 Italy: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 19 Spain: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 20 Spain: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 21 Netherlands: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 22 Netherlands: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 23 Russia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 24 Russia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 25 Rest of Europe: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 26 Rest of Europe: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 27 Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 28 Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 29 China: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 30 China: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 31 India: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 32 India: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 33 Malaysia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 34 Malaysia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 35 Japan: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 36 Japan: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 37 Indonesia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 38 Indonesia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 39 South Korea: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 40 South Korea: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 41 Australia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 42 Australia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 43 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 44 Rest of Asia Pacific: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 45 Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 46 Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 47 Saudi Arabia: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 48 Saudi Arabia: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 49 UAE: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 50 UAE: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 51 Israel: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 52 Israel: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 53 South Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 54 South Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 55 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 56 Rest of Middle East & Africa: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 57 Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 58 Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 59 Mexico: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 60 Mexico: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 61 Brazil: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 62 Brazil: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 63 Argentina: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 64 Argentina: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

Table 65 Rest of Latin America: Personalized Medicine Biomarkers Market, by Indication, 2020-2034 (USD Billion)

Table 66 Rest of Latin America: Personalized Medicine Biomarkers Market, by Application, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Personalized Medicine Biomarkers Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Personalized Medicine Biomarkers Market, by Indication, 2024 & 2034 (USD Billion)

Figure 8. Market by Application

Figure 9. Global Personalized Medicine Biomarkers Market, by Application, 2024 & 2034 (USD Billion)